Works matching IS 09024441 AND DT 2022 AND VI 109 AND IP 1

Results: 15
    1
    2
    3
    4

    A retrospective observational research study to describe the real‐world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 1, p. 90, doi. 10.1111/ejh.13775
    By:
    • Claudiani, Simone;
    • Janssen, Jeroen J. W. M.;
    • Byrne, Jenny;
    • Smith, Graeme;
    • Blijlevens, Nicole;
    • Raghavan, Manoj;
    • Smith, Matthew;
    • Clark, Richard E.;
    • Mclain‐Smith, Susan;
    • Carter, Angela M.;
    • Milojkovic, Dragana;
    • Apperley, Jane F.
    Publication type:
    Article
    5
    6

    Mixed T cell CHIMERISM in bone marrow at day+30 after allogeneic stem cell transplantation: Correlation with acute GVHD grades III–IV and no impact on relapse and overall survival.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 1, p. 83, doi. 10.1111/ejh.13772
    By:
    • Guidotti, Samantha;
    • Bassi, Simona;
    • Rossi, Angela;
    • Borotti, Elena;
    • Cortellazzi, Pilade;
    • Ferrarese, Diego;
    • Ronda, Elena;
    • Scarpa, Alice;
    • Schiro, Alice;
    • Merli, Francesco;
    • Prezioso, Lucia;
    • Bonifazi, Francesca;
    • Narni, Franco;
    • Fabrizi, Enrico;
    • Vallisa, Daniele
    Publication type:
    Article
    7
    8
    9
    10

    Multistep pathogenesis of chronic myelomonocytic leukemia in patients.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 1, p. 50, doi. 10.1111/ejh.13768
    By:
    • Geissler, Klaus;
    • Jäger, Eva;
    • Barna, Agnes;
    • Gurbisz, Michael;
    • Marschon, Renate;
    • Graf, Temeida;
    • Nösslinger, Thomas;
    • Pfeilstöcker, Michael;
    • Machherndl‐Spandl, Sigrid;
    • Stauder, Reinhard;
    • Zebisch, Armin;
    • Sill, Heinz;
    • Öhler, Leopold;
    • Kusec, Rajko;
    • Hoermann, Gregor;
    • Valent, Peter
    Publication type:
    Article
    11

    Retrospective analysis of the safety of peripherally inserted catheters versus implanted port catheters during first‐line treatment for patients with diffuse large B‐cell lymphoma.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 1, p. 41, doi. 10.1111/ejh.13767
    By:
    • Pénichoux, Juliette;
    • Rio, Julien;
    • Kammoun, Leila;
    • Vermeulin, Thomas;
    • Pepin, Louis‐Ferdinand;
    • Camus, Vincent;
    • Dubois, Sydney;
    • Bouclet, Florian;
    • Alani, Mustafa;
    • Contentin, Nathalie;
    • Leprêtre, Stéphane;
    • Stamatoullas, Aspasia;
    • Lanic, Hélène;
    • Lemasle, Emilie;
    • Ménard, Anne‐Lise;
    • Lenain, Pascal;
    • Gilles‐Baray, Marie;
    • Georgescu, Dragos;
    • Clatot, Florian;
    • Tilly, Hervé
    Publication type:
    Article
    12
    13
    14

    Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care: A multicenter international study.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 1, p. 58, doi. 10.1111/ejh.13769
    By:
    • Ito, Tomoki;
    • Sanford, David;
    • Tomuleasa, Ciprian;
    • Hsiao, Hui‐Hua;
    • Olivera, Leonardo José Enciso;
    • Enjeti, Anoop Kumar;
    • Conca, Alberto Gimenez;
    • del Castillo, Teresa Bernal;
    • Girshova, Larisa;
    • Martelli, Maria Paola;
    • Guvenc, Birol;
    • Bui, Cat N.;
    • Delgado, Alex;
    • Duan, Yinghui;
    • Guijarro, Belen Garbayo;
    • Llamas, Cynthia;
    • Lee, Je‐Hwan
    Publication type:
    Article
    15

    Issue Information.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 1, p. 1, doi. 10.1111/ejh.13657
    Publication type:
    Article